News

• Kancera provides new information on the ROR project in connection with the “U.S. Cancer Immunotherapy Partnering Mission”

  17 September 2014

• Interim Report for Kancera AB (publ) Q2 2014

  22 August 2014

• Interim Report for Kancera AB (publ) Q1 2014

  23 May 2014

• Kancera AB files patent for HDAC6 inhibitors against cancer

  14 May 2014

• Update on the result of the collaboration between Kancera and Thomas Helleday

  25 April 2014

• Full Year Report for Kancera AB (publ) 2013 January 1 – December 31, 2013

  21 February 2014

• Kancera initiates the development of a vaccine against ROR to prevent relapse of cancer

  22 January 2014

• Kancera announces the discovery of a new class of compounds against cancer

  3 December 2013

• Interim Report for Kancera AB (publ) Q3 2013

  8 November 2013

• Interim Report for Kancera AB (publ) Q2 2013

  23 August 2013